- Home
- VLGEA vs PLRX Comparison
VLGEA vs PLRX Comparison
Compare VLGEA & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLGEA
- PLRX
- Stock Information
- Founded
- VLGEA 1937
- PLRX 2015
- Country
- VLGEA United States
- PLRX United States
- Employees
- VLGEA N/A
- PLRX N/A
- Industry
- VLGEA Food Chains
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- VLGEA Consumer Staples
- PLRX Health Care
- Exchange
- VLGEA Nasdaq
- PLRX Nasdaq
- Market Cap
- VLGEA 594.9M
- PLRX 641.5M
- IPO Year
- VLGEA N/A
- PLRX 2020
- Fundamental
- Price
- VLGEA $31.82
- PLRX $13.49
- Analyst Decision
- VLGEA
- PLRX Strong Buy
- Analyst Count
- VLGEA 0
- PLRX 7
- Target Price
- VLGEA N/A
- PLRX $40.50
- AVG Volume (30 Days)
- VLGEA 31.9K
- PLRX 600.1K
- Earning Date
- VLGEA 12-03-2024
- PLRX 11-07-2024
- Dividend Yield
- VLGEA 3.14%
- PLRX N/A
- EPS Growth
- VLGEA 2.47
- PLRX N/A
- EPS
- VLGEA 3.48
- PLRX N/A
- Revenue
- VLGEA $2,257,909,000.00
- PLRX N/A
- Revenue This Year
- VLGEA N/A
- PLRX N/A
- Revenue Next Year
- VLGEA N/A
- PLRX N/A
- P/E Ratio
- VLGEA $9.14
- PLRX N/A
- Revenue Growth
- VLGEA 3.42
- PLRX N/A
- 52 Week Low
- VLGEA $24.57
- PLRX $10.22
- 52 Week High
- VLGEA $33.99
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- VLGEA 49.34
- PLRX 46.75
- Support Level
- VLGEA $31.24
- PLRX $12.53
- Resistance Level
- VLGEA $32.73
- PLRX $15.00
- Average True Range (ATR)
- VLGEA 0.96
- PLRX 0.74
- MACD
- VLGEA -0.06
- PLRX -0.11
- Stochastic Oscillator
- VLGEA 45.82
- PLRX 34.95
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.